A detailed history of Zega Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Zega Financial, LLC holds 1,470 shares of ABBV stock, worth $252,443. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,470
Previous 4,374 66.39%
Holding current value
$252,443
Previous $750 Million 61.3%
% of portfolio
0.04%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $475,791 - $578,854
-2,904 Reduced 66.39%
1,470 $290 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $677,051 - $790,644
4,374 New
4,374 $750 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $212,729 - $239,583
1,546 New
1,546 $240 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Zega Financial, LLC Portfolio

Follow Zega Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zega Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zega Financial, LLC with notifications on news.